Euglycemic diabetic ketoacidosis: A rare but serious side effect of sodium-glucose co-transporter 2 inhibitors.
SGLT-2 抑制劑的罕見但嚴重副作用:正常血糖的糖尿病性酮酸中毒。
World J Cardiol 2022-11-08
A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care.
次級護理中使用鈉葡萄糖共同轉運蛋白-2抑製劑相關的一系列糖尿病酮酸中毒。
Diabetes Metab Syndr 2023-01-05
Euglycemic diabetic ketoacidosis associated with ST segment elevation myocardial infarction following SGLT-2 inhibitor therapy.
SGLT-2 抑制劑治療後伴隨ST段抬高型心肌梗塞的正常血糖糖尿病性酮酸中毒。
Am J Emerg Med 2023-08-07
Unsuspected diabetic ketoacidosis after myocardial infarction in a patient treated with SGLT2 inhibitor increased length of stay in the hospital: how can it be prevented? A case report.
SGLT2 抑制劑治療的病人在心肌梗塞後出現不明顯的糖尿病酮酸中毒:如何預防?一個病例報告。
Eur Heart J Case Rep 2023-09-09
Balancing Risks and Benefits: Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis.
平衡風險與益處:鈉葡萄糖共轉運輸蛋白2抑制劑與糖尿病酮酸中毒的風險。
Metabolites 2024-03-29
Beyond the Benefits: A Case Study on the Complications of Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors (Euglycemic Diabetic Ketoacidosis (DKA) and Takotsubo Cardiomyopathy).
SGLT2抑制劑(Euglycemic Diabetic Ketoacidosis (DKA))和 Takotsubo 心肌病的併發症:一個個案研究。
Cureus 2024-03-30
Diabetic Ketoacidosis as an Effect of Sodium-Glucose Cotransporter 2 Inhibitor: Real World Insights.
SGLT2 抑制劑導致的糖尿病酮酸中毒:現實世界的洞察。
Diabetes Metab J 2024-06-10